CASP2 and metabolic dysfunction-associated steatotic liver disease: To assess whether the early and age-related proteomic changes in Casp2C320S livers are similar or distinct to gene expression alterations associated with MASLD progression, we also compared the liver proteome changes from caspase-2-deficient mice to the disease-associated hepatocyte (daHep) gene signature (47).